Uni Biosciences
Beijing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
An antibody-focused biotech developing novel biologics for cancer and autoimmune diseases.
OncologyImmunology
Technology Platform
Employs integrated antibody discovery and engineering platforms to generate and optimize therapeutic monoclonal and bispecific antibodies.
Opportunities
Partnerships with larger pharmaceutical companies seeking to bolster their oncology and immunology pipelines could provide non-dilutive funding and development expertise.
Risk Factors
High technical and clinical development risk associated with novel antibody constructs, alongside intense competition for funding and talent.
Competitive Landscape
Operates in the highly competitive antibody therapeutics space, requiring differentiation through novel targets, superior engineering, or unique biological insights.